INCY Incyte Corp
Price (delayed)
$72.11
Market cap
$13.96B
P/E Ratio
450.69
Dividend/share
N/A
EPS
$0.16
Enterprise value
$12.3B
Incyte Corp is an American pharmaceutical company based in Alapocas, Delaware. The company was founded in Palo Alto, California in 1991 and went public in 1993. Incyte has one drug,
Highlights
Incyte's revenue has increased by 15% YoY and by 4.1% from the previous quarter
INCY's gross profit is up by 14% year-on-year and by 3.9% since the previous quarter
The company's quick ratio fell by 48% YoY but it rose by 9% QoQ
INCY's equity is down by 34% year-on-year but it is up by 9% since the previous quarter
INCY's net income has dropped by 95% year-on-year
INCY's EPS has shrunk by 94% YoY and by 6% QoQ
Key stats
What are the main financial stats of INCY
Market
Valuations
Earnings
Shares outstanding
193.52M
Market cap
$13.96B
Enterprise value
$12.3B
Price to earnings (P/E)
450.69
Price to book (P/B)
4.03
Price to sales (P/S)
3.52
EV/EBIT
38.58
EV/EBITDA
30.14
EV/Sales
2.9
Revenue
$4.24B
Gross profit
$3.93B
Operating income
$61.37M
Net income
$32.62M
EBIT
$318.91M
EBITDA
$408.16M
Free cash flow
$249.07M
Per share
Balance sheet
Liquidity
EPS
$0.16
EPS diluted
$0.15
Free cash flow per share
$1.2
Book value per share
$17.9
Revenue per share
$20.48
TBVPS
$24.99
Total assets
$5.44B
Total liabilities
$2B
Debt
$37.96M
Equity
$3.45B
Working capital
$1.6B
Debt to equity
0.01
Current ratio
1.97
Quick ratio
1.84
Net debt/EBITDA
-4.05
Margins
Efficiency
Dividend
EBITDA margin
9.6%
Gross margin
92.6%
Net margin
0.8%
Operating margin
1.4%
Return on assets
0.6%
Return on equity
0.9%
Return on invested capital
15.8%
Return on capital employed
8.4%
Return on sales
7.5%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
INCY stock price
How has the Incyte stock price performed over time
Intraday
1.02%
1 week
2.4%
1 month
-1.85%
1 year
19.53%
YTD
4.4%
QTD
4.4%
Financial performance
How have Incyte's revenue and profit performed over time
Revenue
$4.24B
Gross profit
$3.93B
Operating income
$61.37M
Net income
$32.62M
Gross margin
92.6%
Net margin
0.8%
The net margin has dropped by 95% year-on-year
INCY's net income has dropped by 95% year-on-year
INCY's operating margin has dropped by 92% year-on-year
Incyte's operating income has plunged by 90% YoY
Growth
What is Incyte's growth rate over time
Valuation
What is Incyte stock price valuation
P/E
450.69
P/B
4.03
P/S
3.52
EV/EBIT
38.58
EV/EBITDA
30.14
EV/Sales
2.9
INCY's EPS has shrunk by 94% YoY and by 6% QoQ
INCY's P/E is 81% above its last 4 quarters average of 249.3
INCY's equity is down by 34% year-on-year but it is up by 9% since the previous quarter
The stock's price to book (P/B) is 18% less than its 5-year quarterly average of 4.9 but 9% more than its last 4 quarters average of 3.7
INCY's P/S is 34% below its 5-year quarterly average of 5.3 but 7% above its last 4 quarters average of 3.3
Incyte's revenue has increased by 15% YoY and by 4.1% from the previous quarter
Efficiency
How efficient is Incyte business performance
INCY's return on assets has dropped by 94% year-on-year
The ROE has plunged by 93% YoY but it has grown by 13% from the previous quarter
INCY's ROS has shrunk by 67% YoY but it is up by 10% QoQ
The ROIC has plunged by 66% YoY but it has increased by 19% from the previous quarter
Dividends
What is INCY's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for INCY.
Financial health
How did Incyte financials performed over time
Incyte's total assets is 173% more than its total liabilities
The company's quick ratio fell by 48% YoY but it rose by 9% QoQ
The current ratio has contracted by 47% YoY but it has grown by 5% from the previous quarter
The debt is 99% smaller than the equity
INCY's equity is down by 34% year-on-year but it is up by 9% since the previous quarter
The debt is up by 18% since the previous quarter and by 16% year-on-year
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.